DGX
Price
$156.60
Change
+$2.22 (+1.44%)
Updated
Sep 16, 03:12 PM (EDT)
36 days until earnings call
TMO
Price
$612.06
Change
+$0.89 (+0.15%)
Updated
Sep 16, 12:56 PM (EDT)
37 days until earnings call
Ad is loading...

DGX vs TMO

Header iconDGX vs TMO Comparison
Open Charts DGX vs TMOBanner chart's image
Quest Diagnostics
Price$156.60
Change+$2.22 (+1.44%)
Volume$200
CapitalizationN/A
Thermo Fisher Scientific
Price$612.06
Change+$0.89 (+0.15%)
Volume$600
CapitalizationN/A
View a ticker or compare two or three
DGX vs TMO Comparison Chart
Loading...
DGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DGX vs. TMO commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGX is a Buy and TMO is a Buy.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (DGX: $154.38 vs. TMO: $611.17)
Brand notoriety: DGX and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DGX: 68% vs. TMO: 84%
Market capitalization -- DGX: $14.74B vs. TMO: $220.19B
DGX [@Medical Specialties] is valued at $14.74B. TMO’s [@Medical Specialties] market capitalization is $220.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DGX’s FA Score shows that 3 FA rating(s) are green whileTMO’s FA Score has 2 green FA rating(s).

  • DGX’s FA Score: 3 green, 2 red.
  • TMO’s FA Score: 2 green, 3 red.
According to our system of comparison, DGX is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DGX’s TA Score shows that 3 TA indicator(s) are bullish while TMO’s TA Score has 2 bullish TA indicator(s).

  • DGX’s TA Score: 3 bullish, 5 bearish.
  • TMO’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, DGX is a better buy in the short-term than TMO.

Price Growth

DGX (@Medical Specialties) experienced а +0.95% price change this week, while TMO (@Medical Specialties) price change was +0.04% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.90%. For the same industry, the average monthly price growth was +7.65%, and the average quarterly price growth was +0.80%.

Reported Earning Dates

DGX is expected to report earnings on Oct 22, 2024.

TMO is expected to report earnings on Oct 23, 2024.

Industries' Descriptions

@Medical Specialties (+5.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($220B) has a higher market cap than DGX($14.7B). TMO has higher P/E ratio than DGX: TMO (37.38) vs DGX (17.99). TMO YTD gains are higher at: 15.371 vs. DGX (13.811). TMO has higher annual earnings (EBITDA): 11.1B vs. DGX (1.73B). TMO has more cash in the bank: 8.08B vs. DGX (686M). DGX has less debt than TMO: DGX (5.5B) vs TMO (34.9B). TMO has higher revenues than DGX: TMO (42.9B) vs DGX (9.25B).
DGXTMODGX / TMO
Capitalization14.7B220B7%
EBITDA1.73B11.1B16%
Gain YTD13.81115.37190%
P/E Ratio17.9937.3848%
Revenue9.25B42.9B22%
Total Cash686M8.08B8%
Total Debt5.5B34.9B16%
FUNDAMENTALS RATINGS
DGX vs TMO: Fundamental Ratings
DGX
TMO
OUTLOOK RATING
1..100
2077
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
2320
SMR RATING
1..100
6160
PRICE GROWTH RATING
1..100
2233
P/E GROWTH RATING
1..100
4450
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DGX's Valuation (8) in the Servicestothe Health Industry industry is somewhat better than the same rating for TMO (69) in the Medical Specialties industry. This means that DGX’s stock grew somewhat faster than TMO’s over the last 12 months.

TMO's Profit vs Risk Rating (20) in the Medical Specialties industry is in the same range as DGX (23) in the Servicestothe Health Industry industry. This means that TMO’s stock grew similarly to DGX’s over the last 12 months.

TMO's SMR Rating (60) in the Medical Specialties industry is in the same range as DGX (61) in the Servicestothe Health Industry industry. This means that TMO’s stock grew similarly to DGX’s over the last 12 months.

DGX's Price Growth Rating (22) in the Servicestothe Health Industry industry is in the same range as TMO (33) in the Medical Specialties industry. This means that DGX’s stock grew similarly to TMO’s over the last 12 months.

DGX's P/E Growth Rating (44) in the Servicestothe Health Industry industry is in the same range as TMO (50) in the Medical Specialties industry. This means that DGX’s stock grew similarly to TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DGXTMO
RSI
ODDS (%)
Bearish Trend 4 days ago
56%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
66%
Bearish Trend 4 days ago
48%
Momentum
ODDS (%)
Bearish Trend 4 days ago
47%
Bearish Trend 4 days ago
49%
MACD
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 5 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 5 days ago
66%
Bullish Trend 8 days ago
63%
Declines
ODDS (%)
Bearish Trend 11 days ago
48%
Bearish Trend 4 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
57%
Aroon
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
72%
View a ticker or compare two or three
Ad is loading...
DGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPC24.180.85
+3.64%
Tutor Perini Corp
BMI209.085.28
+2.59%
Badger Meter
VNDA5.100.11
+2.20%
Vanda Pharmaceuticals
KMB143.521.14
+0.80%
Kimberly-Clark Corp
SYPR1.57-0.05
-3.09%
Sypris Solutions

DGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DGX has been loosely correlated with LH. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if DGX jumps, then LH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGX
1D Price
Change %
DGX100%
-0.25%
LH - DGX
65%
Loosely correlated
+0.49%
HOLX - DGX
39%
Loosely correlated
+0.91%
TMO - DGX
36%
Loosely correlated
-0.42%
QGEN - DGX
36%
Loosely correlated
+1.73%
FLGT - DGX
34%
Loosely correlated
+1.54%
More